Reported covered position: Member of Congress, California 1998-2012
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Food related issues; H.R. 4828, S. 2322 - the CURD Act
Removing Barriers to Allergy Diagnostic Testing Act of 2018
Client: THERMO FISHER SCIENTIFIC · Firm: FAEGRE BAKER DANIELS CONSULTING
Asthma policies and diagnostic allergy test coverage; H.R. 5541 - Removing Barriers to Allergy Diagnostic Testing Act of 2018
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Food related issues; H.R. 4828, S. 2322 - the CURD Act
Advocated for reinstating individual deductions for costs associated with higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 7 | 2017–2018 |
| RENOVA SOLAR | 7 | 2017–2018 |
| COLLEGIUM PHARMACEUTICAL INC | 6 | 2016–2017 |
| NATIONAL ASSOCIATION OF BOARDS OF PHARMACY | 5 | 2017–2018 |
| PROOVE BIOSCIENCES | 5 | 2016 |
| BIODELIVERY SERVICES INTERNATIONAL, INC. | 4 | 2016–2017 |
| COALITION FOR A SECURE AND TRANSPARENT INTERNET | 4 | 2018 |
| NOVAVAX | 4 | 2016 |
| THERMO FISHER SCIENTIFIC | 4 | 2018 |
| AXIAL HEALTHCARE | 3 | 2016 |
| TRUST FOR AMERICA'S HEALTH | 3 | 2018 |
| MEDICAL TRANSPORTATION ACCESS COALITION | 1 | 2017 |
| SCIENTIST | 1 | 2018 |
SUPPORT for Patients and Communities Act
Client: AMERICAN ACADEMY OF ADDICTION PSYCHIATRY · Firm: FAEGRE BAKER DANIELS CONSULTING
General administration and Congressional activities related to opioid abuse prevention and treatment; H.R. 6 Support Act
SUPPORT for Patients and Communities Act
Client: NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Firm: FAEGRE BAKER DANIELS CONSULTING
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Food related issues; H.R. 4828, S. 2322 - the CURD Act
2018 · third_quarter · Q3
Fiscal year 2019 VA and labor HHS appropriations legislation; issues related to sepsis treatment and antibiotic stewardship
Asthma policies and diagnostic allergy test coverage; H.R. 5541 - Removing Barriers to Allergy Diagnostic Testing Act of 2018
Drug shortage prevention and abuse-deterrent pseudophedrine.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR A SECURE AND TRANSPARENT INTERNET via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · 3A
Advocate for public access to transparent, non-anonymous WHOIS data
Filing targets: HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), SENATE
COALITION FOR A SECURE AND TRANSPARENT INTERNET via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Advocate for public access to transparent, non-anonymous WHOIS data
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Pharmacy regulation; DEA Clearinghouse Act of 2018
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs: H.R. 6 SUPPORT Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · 3A
General administration and Congressional activities related to opioid abuse prevention and treatment; H.R. 6 Support Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Opposition to prescription drug importation legislation
Illicit prescription drug sales online; rouge internet drug sellers; dangers of counterfeit medicines
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · Q3
General administration and Congressional activities related to opioid abuse prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCIENTIST via FAEGRE BAKER DANIELS CONSULTING
2018 · third_quarter · RR
Digital marketplace for research and development services
COALITION FOR A SECURE AND TRANSPARENT INTERNET via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Advocate for public access to transparent, non-anonymous WHOIS data
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRUST FOR AMERICA'S HEALTH via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Addiction prevention, treatment and recovery efforts
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Supporting rooftop solar installation and use initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
General administration and Congressional activities related to opioid abuse prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Asthma policies and diagnostic allergy test coverage.
Drug shortage prevention and abuse-deterrent pseudophedrine.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Opposition to prescription drug importation legislation; online drug safety and opioids sold online
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · Q2
Medication safety, pharmacy regulation, and the opioid epidemic; Prescription drug monitoring programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRUST FOR AMERICA'S HEALTH via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Addiction prevention, treatment and recovery efforts
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR A SECURE AND TRANSPARENT INTERNET via FAEGRE BAKER DANIELS CONSULTING
2018 · second_quarter · RR
Advocate for public access to transparent, non-anonymous WHOIS data
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
General energy issues related to uranium mining and milling
General energy issues related to uranium mining and milling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Supporting rooftop solar installation and use initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
General administration and Congressional activities related to opioid abuse prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Data security and privacy matters
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Drug shortage prevention and abuse-deterrent pseudophedrine.
Asthma policies and diagnostic test reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Opposition to prescription drug importation legislation; online drug safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · Q1
Medication safety, pharmacy regulation, and the opioid epidemic
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THERMO FISHER SCIENTIFIC via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · RR
Asthma policies and diagnostic test reimbursement. Drug shortage prevention and abuse-deterrent pseudophedrine.
Asthma policies and diagnostic test reimbursement. Drug shortage prevention and abuse-deterrent pseudophedrine.
TRUST FOR AMERICA'S HEALTH via FAEGRE BAKER DANIELS CONSULTING
2018 · first_quarter · RR
Addiction prevention, treatment and recovery efforts
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · 2A
General energy issues related to uranium mining and milling; air emission rules
General energy issues related to uranium mining and milling
Filing targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · 3A
General energy issues related to uranium mining and milling; air emission rules
General energy issues related to uranium mining and milling; national monument boundaries
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · 3A
Food related issues
Agriculture related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · 2A
General energy issues related to uranium mining and milling; air emission rules
General energy issues related to uranium mining and milling
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
General energy issues related to uranium mining and milling
General energy issues related to uranium mining and milling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Opposition to prescription drug importation legislation; online drug safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Medication safety, pharmacy regulation, and the opioid epidemic
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Supporting rooftop solar installation and use initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
General administration and Congressional activities related to opioid abuse prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · Q4
Data security and privacy matters
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BOARDS OF PHARMACY via FAEGRE BAKER DANIELS CONSULTING
2017 · fourth_quarter · RR
Medication safety, pharmacy regulation, and the opioid epidemic
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
General energy issues related to uranium mining and milling
General energy issues related to uranium mining and milling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
Opposition to prescription drug importation legislation; online drug safety
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
Supporting rooftop solar installation and use initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
General administration and Congressional activities related to opioid abuse prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2017 · third_quarter · Q3
Data security and privacy matters
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
MEDICAL TRANSPORTATION ACCESS COALITION via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · RR
Engage on legislation and policies impacting beneficiary access to non-emergency medical transportation issues.
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · 2A
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · 2A
General energy issues related to uranium mining and milling
General energy issues related to uranium mining and milling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
General energy issues related to uranium mining and milling
General energy issues related to uranium mining and milling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
Opposition to prescription drug importation legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
Supporting rooftop solar installation and use initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
General administration and Congressional activities related to opioid abuse prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · Q2
Data security and privacy matters
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
BIODELIVERY SERVICES INTERNATIONAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · second_quarter · 2T
Access to innovative therapies for addiction treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Supporting rooftop solar installation and use initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
General administration and Congressional activities related to opioid abuse prevention and treatment; CARA legislation; TREAT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Data security and privacy matters
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Opposition to prescription drug importation legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · 1A
Pediatric research and healthcare; Medicaid health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGIUM PHARMACEUTICAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Access to abuse deterrent formulations of opioids
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIODELIVERY SERVICES INTERNATIONAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Access to innovative therapies for addiction treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · RA
Opposition to prescription drug importation legislation
ENERGY FUELS RESOURCES INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
General energy issues related to uranium mining and milling
General energy issues related to uranium mining and milling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · Q1
Food related issues
Agriculture related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RENOVA SOLAR via FAEGRE BAKER DANIELS CONSULTING
2017 · first_quarter · RR
Supporting rooftop solar installation and use initiatives
PROOVE BIOSCIENCES via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · 4T
CARA bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGIUM PHARMACEUTICAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
Access to abuse deterrent formulations of opioids
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIODELIVERY SERVICES INTERNATIONAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
Access to innovative therapies for addiction treatment
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
Food related issues
Agriculture related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROOVE BIOSCIENCES via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
CARA bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
General administration and Congressional activities related to opioid abuse prevention and treatment; CARA legislation; TREAT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
Data security and privacy matters.
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
NOVAVAX via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · Q4
Vaccine policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIODELIVERY SERVICES INTERNATIONAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2016 · fourth_quarter · RR
Access to innovative therapies for addiction treatment
NOVAVAX via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
Vaccine policy
Filing targets: Health & Human Services, Dept of (HHS)
PROOVE BIOSCIENCES via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
CARA bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
General administration and Congressional activities related to opioid abuse prevention and treatment; CARA legislation; TREAT Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
21ST CENTURY PRIVACY COALITION via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
Data security and privacy matters.
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COLLEGIUM PHARMACEUTICAL, INC. via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
Access to abuse deterrent formulations of opioids
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SARGENTO FOODS INC. via FAEGRE BAKER DANIELS CONSULTING
2016 · third_quarter · Q3
Agriculture related issues
Food related issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVAVAX via FAEGRE BAKER DANIELS CONSULTING
2016 · second_quarter · Q2
Vaccine policy
Filing targets: Health & Human Services, Dept of (HHS)
COLLABORATIVE FOR EFFECTIVE PRESCRIPTION OPIOID POLICIES via FAEGRE BAKER DANIELS CONSULTING
2016 · second_quarter · Q2
Opioid legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE